Next Article in Journal
Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
Next Article in Special Issue
Comparison of Perceived and Observed Hand Hygiene Compliance in Healthcare Workers in MERS-CoV Endemic Regions
Previous Article in Journal
Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Healthcare
Volume 6
Issue 3
10.3390/healthcare6030109
healthcare-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Assessment of Health Information Technology Interventions in Evidence-Based Medicine: A Systematic Review by Adopting a Methodological Evaluation Framework

by
Stella C. Christopoulou
1,2,*,
Theodore Kotsilieris
2 and
Ioannis Anagnostopoulos
1
1
Department of Computer Science and Biomedical Informatics, School of Sciences, University of Thessaly, Papasiopoulou 2-4, Galaneika, Lamia 35100, Greece
2
Department of Business Administration, Health & Welfare Units Administration Division, Technological Educational Institute of Peloponnese, Antikalamos, Kalamata 24100, Greece
*
Author to whom correspondence should be addressed.
Healthcare 2018, 6(3), 109; https://doi.org/10.3390/healthcare6030109
Submission received: 10 July 2018 / Revised: 15 August 2018 / Accepted: 28 August 2018 / Published: 31 August 2018
(This article belongs to the Special Issue Nutrition and Public Health)
Browse Figures
Versions Notes

Abstract

:
Background: The application of Health Information Technologies (HITs) can be an effective way to advance medical research and health services provision. The two-fold objective of this work is to: (i) identify and review state-of-the-art HITs that facilitate the aims of evidence-based medicine and (ii) propose a methodology for HIT assessment. Methods: The systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Furthermore, we consolidated existing knowledge in the field and proposed a Synthesis Framework for the Assessment of Health Information Technology (SF/HIT) in order to evaluate the joint use of Randomized Controlled Trials (RCTs) along with HITs in the field of evidence-based medicine. Results: 55 articles met the inclusion criteria and refer to 51 (RCTs) published between 2008 and 2016. Significant improvements in healthcare through the use of HITs were observed in the findings of 31 out of 51 trials—60.8%. We also confirmed that RCTs are valuable tools for assessing the effectiveness, acceptability, safety, privacy, appropriateness, satisfaction, performance, usefulness and adherence. Conclusions: To improve health service delivery, RCTs apply and exhibit formalization by providing measurable outputs. Towards this direction, we propose the SF/HIT as a framework which may help researchers to carry out appropriate evaluations and extend their studies.

Graphical Abstract

1. Introduction

The application of Health Information Technology (HIT) has been proposed as a promising solution for the improvement of efficiency, effectiveness, quality of healthcare delivery. Some of the most important benefits of HITs are the reduction of medical errors and costs, the improvement of patients’ quality of life and the enhancement of medical decision making.
Recent research efforts have focused on the potential of HIT to transform the delivery of health care. Despite the fact that interoperable and multipurpose HIT systems have been developed, their widespread adoption in the course of care has been limited by the lack of knowledge about their types, the existence of standardized assessment frameworks/methodologies and classification methods of their outcomes that will improve health care provision. The assessment and reporting of HIT systems features requires standardized methods and classification procedures.
Evidence-Based Health Informatics (EBHI) can be defined as the conscientious, explicit, and judicious use of current best evidence to support a health care decision that employs Information Technologies (ITs) [1]. Towards this direction, Randomized Controlled Trials (RCTs) are considered to be a well-established experimental clinical tool, suitable not only for evaluating the efficacy of interventions, but also for supporting the conduct of an adequately designed systematic review [2].
Both EBHI and RCTs are currently at the forefront of physicians’ support for clinical decision-making. Thus, this work focuses on recent research efforts that examine whether and to what extent HITs are employed for evidence-based medicine purposes and, moreover, to propose a methodology for HIT assessment in health care delivery.
Due to the key role played by information technology in every aspect of health care, the aforementioned benefits have to be validated. Thus, we identified four broad Research Questions (RQs) that will guide the rest of our work:
  • RQ1. Are there any classification methods for the detailed description of the results associated with HITs, and to what extent? It remains unclear whether the advances of HITs in recent years take into account or suggest such evaluation models or standards.
  • RQ2. Is there any framework or methodology to follow for the assessment of HITs in order to evaluate, compare or extend results from other studies and systematic reviews? It is uncertain whether comprehensive and standardized assessment frameworks/methodologies have been proposed, or if further investigation and study is required in the field.
  • RQ3. Which are the most established HITs (i.e., HIT forms in accordance with their functional capabilities and the categories of applied Information science) that support evidence-based medicine and are integrated in medical and nursing practices?
  • RQ4. What are the features, the outcomes and the types of HIT interventions of the included studies in this research, and their classification in accordance with the medical/health domain?

2. Materials and Methods

The main goal of this study is to map out and propose a common and strict research method so that it leads to comparable findings among many studies. To achieve this, we used a previous systematic review of ours as a model of this study. More analytically, the two-fold objective of this article is to: (i) identify and review the state-of-the-art HITs with respect to the value and functionalities designed to work with them that facilitate the aims of evidence-based medicine, and (ii) propose a framework for considering the HIT assessment in health care delivery. As a result of these objectives, this work consists of a literature and a systematic review.
Initially, in the literature review, we examined step by step the research methodology of the articles included in our previous systematic review [3] and an unstructured preliminary evaluation framework for HITs emerged. Based on that work, the potential indicators (e.g., meaningfulness, relevance, usefulness, clarity, appropriateness, impact on outcome, etc.) of the proposed framework were developed and validated by a Delphi study [4].
More analytically, the Delphi method was used to collect experts’ opinions regarding key indicators (i.e., a classification list of SF/HIT categories/sub-categories and items) (supplementary file SF-HIT.pdf) for the Synthesis Framework for the Assessment of Health Information Technology (SF/HIT). Within this framework, two key domains (Health domain and HITs) were identified. The collection methodology of the appropriate articles was designed accordingly and the literature review (in Section 2.1) was conducted to consider related studies that employ HIT platforms to advance issues related with medicine and health care (addressing RQ1 and RQ2).
Thus, as depicted in Figure 1, we initially gathered the articles referred in the literature review and then we further categorized them (Tables S1 and S2 in supplementary file sup_basic.pdf) according to specific criteria as described in Section 2.2.
Then, the SF/HIT framework (in the form of a standard guide as presented in the supplementary file SF-HIT.pdf) was validated through a Delphi consultation. Subsequently, SF/HIT was applied in this systematic review so as to collate all evidence fitting pre-specified eligibility criteria in an attempt to address specific research questions [5].
Moreover, in order to respond to RQ3 and RQ4, we used data collected in a previous work of ours [3]. More specifically, in this systematic review, we considered only studies that involve RCTs, since they provide the most appropriate method for assessing the effectiveness, cost effectiveness, acceptability and safety of an intervention in evidence-based medicine [6,7,8]. The quality of our study was assessed according to the basic criteria of the Cochrane Risk of Bias Assessment Tool [5], while it was conducted in accordance to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [9].
In addition, we applied the CONSORT-EHEALTH Checklists [10] to further assess HITs-based healthcare provision. Finally, we considered RCTs studies with at least one published article in order to compile the basic material of our study. Details about the applied methods, the electronic databases and the queries involved, as well as the data collection process are provided in our previous review [3].

2.1. Related Work

A short literature survey depicts HIT applications spanning from short message services in medical environments and high-performing healthcare systems [11,12] to tele-monitoring [13,14], e-medication treatment [15], Electronic Health Record (EHR) systems [16] and sensor technologies [17].
The evaluation of HITs, the so-called Health Technology Assessment (HTA), is a crucial multidisciplinary activity in research and medical practice that systematically examines and evaluates the properties, effects, and/or impacts of health technology [18].
During this literature review on HTA, we identified several methods and taxonomies (addressing RQ1 and RQ2) that classify the assessment and properties of the evaluations of HITs.
The International Network of Health Technology Assessment Agencies developed a 14-item health technology assessment checklist as further support for a consistent and transparent approach of HTA.
Moreover, the EUR-ASSESS project proposed a framework for conducting and reporting HTA that describes a good practice in both undertaking and reporting HTA, while it also identifies the needs for methodologic development. This framework is complemented by specific recommendations and implementation tools, e.g., by providing the structure of the scientific summary reports and a checklist for the evaluation of methodology and the quality of HTA reports [19].
Also, the EUnetHTA (European net for Healrh Technology Assessment) project developed the HTA Core Model. This is a novel approach that enables effective national and transnational production and sharing of HTA results in a common, structured format and represents a wide range of perspectives [20].
In addition, Dixon et al., in [21], proposed a taxonomy for HITs on behalf of the AHRQ’s (Agency for Healthcare Research and Quality’s) National Resource Center for HIT in the USA. It is organized into 6 major and 28 minor categories with two additional sub-levels, forming a hierarchical and interrelated classification schema for the development, implementation, and evaluation of HITs. A review conducted by Jamal et al. [22] studied the use of health information technologies and systems, examining the impact of Electronic Health Records, Computerized Provider Order-Entries, and Decision Support Systems in medical care. Additionally, the same work examined the level of compliance in respect to evidence-based guidelines among clinicians.
Furthermore, the authors in [23] systematically evaluated the evidence on the effect of health information technology over quality, efficiency, and costs of health care. More specifically, they gathered 257 descriptive and comparative studies, as well as systematic reviews of health information technology from well-established digital libraries. As a result, the authors identified major benefits in terms of increased adherence to guideline-based care, enhanced surveillance and monitoring, and decreased medication errors. Also, the review revealed that preventive health was the main health domain in which improvement was noticed, while decreased utilization of health care services was the major benefit. Furthermore, this study acknowledges the efficacy of HIT for improving quality and efficiency while total development and implementation costs cannot be accurately calculated.
To accelerate the use of HITs, during 2009, the U.S. government introduced the Health Information Technology for Economic and Clinical Health (HITECH) Act [24]. This Act posed new requirements on health care organizations and professionals in terms of meaningful-use criteria, which drive reimbursements from the U.S. government for patient-centered care. The meaningful-use criteria are a set of requirements that health care organizations and professionals must meet for the adoption of HITs.
In the same direction, the authors of [25] examined recent evidence that correlates HIT functionalities (e.g., clinical decision support, computerized provider order entry, patient care reminders, e-prescribing, patient access to electronic records, etc.) with regard to quality, safety, and efficiency metrics. The authors confirm that the most important improvement incurred in HIT evaluations is increased measurement, analysis, and reporting of the effects of contextual and implementation factors.
The review conducted by Buntin et al. [26] included 69 articles that assessed EHR systems, 44 articles that studied order entry systems and 44 articles that evaluated clinical support decision systems. The authors observed that the literature was not clear in determining which criteria that strongly impact the efficient use of HITs had been met. However, the review revealed that the HITs systems improved several aspects of healthcare provision services, without noticing deterioration in any case. The study also determined that articles dealing with more than one substantial operation of HITs had slightly increased positive findings compared to articles that did not consider them at all. This finding is attributed to the fact that including substantial and measurable criteria makes the measurements more accurate. Consequently, the benefits of HITs can be determined more accurately.
Defining a common set of criteria and a strict framework (i.e., participants, type of clinical trial, medical field), the conduct of reviews and meta-analyses will provide sufficient, comparable and reliable results (over satisfaction, effectiveness, usefulness, efficiency, security, user acceptance, etc.), minimizing in parallel the risk of bias. Towards this direction, the next section proposes the framework of a classification system that enables the integration of results from multiple clinical trials and draws conclusions on the usage of HITs.

2.2. The Classification Scheme for the Synthesis of Results

In this work (addressing RQ1 and RQ3), we aim at identifying the functionalities that can be used to prototype health care delivery and to promote health IT evaluation.
Thus, we extend a previous work of ours [3] and we propose a solid classification schema for the development and the assessment of HITs in evidence-based medicine (addressing RQ2).
The Committee on Data Standards for Patient Safety [27] classifies EHR systems on the basis of some core functionalities (e.g., delivery of personal health care services, care management and support processes), as well as by the supported administrative processes (e.g., billing and reimbursement). The classification criteria posed by the Committee include: patient safety, delivery of effective patient care, facilitate management of chronic conditions, efficiency and feasibility of implementation.
In another work, described in [26], HITs are classified by study design, care setting, health IT components, functions included in the meaningful-use criteria, and finally addressed outcomes. Outcomes are classified by their type (e.g., access to care, preventive care, care process, effectiveness, satisfaction, safety, etc.) and their rate (i.e., positive, mixed positive, neutral and negative).
With respect to RQ2, we consolidated the aforementioned existing knowledge and propose a Synthesis Framework for the Assessment of Health Information Technology (SF/HIT) (see also: supplementary file SF-HIT.pdf) for evidence-based medicine that employs HITs (Figure 2). SF/HIT consists of two main categories: (a) the Health Core Domains category (Table S1 in supplementary file sup_basic.pdf); and (b) the Health Information Technology category (Table S2 in supplementary file sup_basic.pdf). SF/HIT aims at filling the gap of HITs assessment in evidence-based medicine and towards this goal it encompasses both the technological aspect of HITs and the outcomes evaluation from the health domain perspective.
According to this methodology, the Health Core Domains category includes the findings associated with health care provision, and is divided into three sub-categories, namely (a) design; (b) annotation; and (c) evaluation.
In the design sub-category, we consider (i) the PRISMA 2009 methodological tool [9]; (ii) the taxonomy related with the experimental type (e.g., prevention, screening, treatment, etc.) of the RCTs [28,29]; as well as (iii) the taxonomy related with the RCT type [28], e.g., open, single blind, etc.). In the annotation sub-category, the trials are annotated under the ICD-10 (International Classification of Diseases—10th Revision) medical terminology [30]. Finally, in the evaluation sub-category we consider (i) the CONSORT statement and checklist [31]; (ii) the assessment of the quality of clinical trial by type [5]; and (iii) the assessment of the quality of clinical trial by rating [5]. The first comprises a 25-item checklist and a flow diagram to provide additional guidance for RCTs, while the second and third are used in order to evaluate bias type (e.g., selection bias, performance bias, attrition bias, etc.) and its level (e.g., high, low, undefined) respectively.
The Health Information Technology category includes the findings associated with the technical aspect of the interventions. Similarly, this category contains three sub-categories, namely (a) development, (b) functionality and (c) evaluation.
The development sub-category, uses a taxonomy based on the Medical Subject Headings (MeSH) classification system [32] (Figure 3).
The functionality sub-category consists of 5 HITs types—CBA (Computer-Based Alerts and reminders systems), CPOE (Computerized Physician Order Entry), DSS (Decision Support Systems), EHR (Electronic Health Record), and other types—that describe the functional capabilities of HITs.
Finally, the evaluation sub-category includes (i) the CONSORT-EHEALTH Checklists [10]; (ii) the impacts by type; and (iii) the impacts by rating. The CONSORT-EHEALTH Checklists stands as a standard evaluation report, while the impacts in the reviewed studies (e.g., in preventive care, adherence/attendance, efficiency, usefulness, effectiveness, etc.) are recorded according to the suggestions described in [26].

2.3. Systematic Review Search Strategy

The implementation of the systematic review followed the PRISMA 2009 flow diagram (Figure 1), and the review authors conducted the initial survey for the collection of the clinical trials and articles using the registry platforms and electronic databases.
The clinical registry platforms we used were the following: Australian and New Zealand Clinical Trials Registry, Cochrane Central Register of Controlled Trials, WHO International Clinical Trials Registry Platform, The European Clinical Trials Database, Chinese Clinical trial registry, Clinical Trials Registry—India, Deutsches Register Klinischer Studien (German Clinical Trials Register), Health Level 7, International Clinical Trials Registry Platform, Iranian Registry of Clinical Trials, International Standardised Randomised Controlled Trial Number, Japan Primary Registries Network, The Netherlands National Trial Register, Pan African Clinical Trials Registry, United States Trials Registry, European Clinical Trials Database, Linked Clinical Trials. Also, the search strategy was performed over the following academic digital libraries: Medline/PubMed, IEEE Xplore, World Health Organization library databases, Google Scholar, Wiley Online Library and Scopus.

2.3.1. Eligibility Criteria

For compiling a solid basis of articles that fall within the concept of HIT interventions, we performed single as well as multi-term queries combined with Boolean operators. In order not to overlook critical synonyms in our queries, we firstly included all related MeSH terms (initial term set). After having collected a significant number of articles from our queried sources, we excluded keywords and terms which appeared rarely, while we added synonyms that appeared with high frequency and were not included in our initial term set. We finally ended on the following keywords and subjects: “computer-interpretable, computer-based, measurement, assessment, evaluation, scale, rating, inventory, monitoring, tool, e-health, telemedicine, tele-health, telecare, care plan, clinical guideline.”
Then, we applied a two-fold eligibility criterion. We considered an article in our review if (i) it referred to at least one RCT and (ii) employed ICT (Information and Communications Technology)—based methods or uses computer-based equipment.
Figure 1 illustrates the details of our search strategy. We initially considered 8062 articles and trials, out of which 6929 were excluded for not meeting criteria 1–5 of step 1. In step 2, 1133 studies were reviewed, and 684 studies were further excluded for not meeting criteria 1–3. Finally, Figure 1 depicts the general and specific eligibility criteria of steps 3, 4, and 5 that led us to the set of the 55 examined articles. Below, we summarize briefly the criteria:
  • Interventional completed trials (RCTs) published between 2008 and 2016;
  • Relative trials are assigned an official registration number, as this is a fundamental requirement from 2004 (i.e., the International Committee of Medical Journal Editors announced that RCTs will be considered for publication only if they are registered before the enrolment of the first patient [33]);
  • Results of the trials are published in at least one article that belongs to well-known and established scholar databases. Therefore, every article is related to one or more trials and vice-versa;
  • Publication language is English.
Due to the heterogeneity of study designs, no meta-analyses were considered. Further details on our search strategy, so as to be replicated by a third person (according to PRISMA checklist item 8), are provided in our preliminary work [3].

2.3.2. Data Extraction and Analysis Process

In Table 1, we depict our analytical assessment in respect to seven items of the Cochrane risk of bias summary (i.e., Sub-category 1.3.2. and 1.3.3. of SF/HIT). More precisely, all the elements are classified using the rationale of the proposed SF/HIT Framework (see also: supplementary file SF-HIT.pdf). Therefore, for every single study/trial in this review, we considered the following categories (Tables S3 and S4 in supplementary file sup_basic.pdf):
  • Category of disease/health domain (e.g., neoplasm, mental, behavioral disorders, etc.) (i.e., Sub-category 1.2.1. of SF/HIT).
  • RCT type (i.e., open label, single blind, double blind, not blinded and unclear) (i.e., Sub-category 1.1.1. of SF/HIT).
  • RCT Experimental type (prevention, screening, treatment, supportive care and health services research) (i.e., Sub-category 1.1.2. of SF/HIT).
  • HITs Functional capabilities (e.g., computer-based alerts and reminders systems, computerized provider order entry, etc.) (i.e., Sub-category 2.2.1. of SF/HIT). To define values for this output, we based on the suggestions made by the authors of [23,34].
  • ICT category—under the MeSH classification system (e.g., telemedicine, medical informatics applications, etc.) (i.e., Sub-category 2.1.1. of SF/HIT).
  • Outcomes/impacts by type (e.g., effectiveness, acceptability, usefulness, etc.) and rating (e.g., positive, negative) (i.e., Sub-categories 2.3.2. and 2.3.3. of SF/HIT).
It should be noted that different or doubtful judgments were discussed and, in case of disagreement, final decisions were recorded after voting between the review authors.

3. Results

Table S3 in supplementary file sup_basic.pdf and Table 2 herein provide analytical and summary information about the included studies/trials (addressing RQ3), according to the ICD-10 classification system.
Moreover, studies/trials were further examined with respect to their: (i) RCT type; (ii) experimental type; (iii) HITs functional capabilities; and (iv) ICT category.
In a similar way, Table S4 in sup_basic.pdf and Table 3 herein depict detailed information and synopsis about the primary outcomes and several dimensions of the impacts by both their type and their rating.

3.1. Descriptive Elements of the Studies and the Types of HIT in Use

As far as RQ4 is concerned, we systematically present the descriptive elements of the studies and the types of HIT-based interventions of the included studies according to the ICD-10 classification system.
● A00–B99: Certain infectious and parasitic diseases (5 studies/5 trials): One trial describes an interactive computer kiosk that was assessed in terms of efficiency and safety, for the management of uncomplicated urinary tract infections in emergency departments [35]. Another one proposes an antiretroviral therapy via mobile phones in sub-Saharan Africa [36]. By using mobile phone reminder messages, the authors of [37] enhance a follow-up medical care for children who are exposed to or infected by HIV in Cameroon. The evaluation is performed in terms of efficiency, efficacy and success. The authors of [38] introduce a two-way mobile phone and a text-messaging system to improve adherence to antiretroviral medication, thus enhancing the communication between people infected by HIV and health professionals by providing effective, ethical, and efficient remote support. Additionally, in [39], the authors assessed the social support and the impact of an Internet-based HIV prevention program.
The above clinical trials were conducted over samples that span between 198 and 720 participants. We estimated an average time of approximately 1.8 years between the beginning of a clinical trial (registration year) and its related publication year.
● C00–D48: Neoplasms (4 studies/4 trials): The trials of this domain (i) study the impact of a web-based intervention that utilizes text messages to improve cancer prevention behaviors among adolescents [40], (ii) evaluate a mobile phone-based, advanced symptom management system of chemotherapy-related toxicity [41], (iii) implement a computer-based communication service [42], and (iv) assess the effectiveness of a Web-Based Colorectal Cancer Screening Patient Decision Aid [43].
All clinical trials were conducted in medium/large samples spanning from 150 up to 3000 individuals. The mean time between the kick-off of a clinical trial (i.e., the registration year) and the publication of the related results was approximately 5.3 years.
● E00–E90: Endocrine, nutritional and metabolic diseases (7 studies/7 trials): The authors in [44] assess an electronic alert system to improve Dyslipidemia Treatment. In [45], the authors evaluate the efficacy and safety of a continuous glucose monitor–based system. Four studies are related to mobile/internet health interventions for patients with diabetes [46,47,48,49], while an innovative study supports the use of artificial pancreas at home as a safe and beneficial option for patients with type I diabetes [50].
Among the examined trials, 5 were conducted in samples of from 36 to 200 individuals, while 2 were conducted in larger ones (from 1485 up to 88001 individuals). Between the initiation of a clinical trial (registration year) and its related publication, the average time was approximately 1.3 years.
● F01–F99: Mental, behavioral and neurodevelopmental disorders (18 studies/18 trials): The trials under this category are related to ICT-based prevention, screening and treatment in the area of mental health. Moreover, studies involve abnormalities in cognitive processes [51,52,53], depression and anxiety [54,55,56,57,58,59,60,61]. It also includes trials related with addictions, such as smoking [62,63,64,65], alcohol use [66,67] and drugs [68].
All clinical trials were conducted over samples that vary from 50 to 4800 individuals. We recorded an average time period of nearly 2.8 years between the registration of a clinical trial and its publication year.
● I00–I99: Diseases of the circulatory system (6 studies/5 trials): The authors of [69,70] studied mobile-based interventions for physical activity in cardiac rehabilitation, while in [71] we reviewed a physical activity intervention for women with young children. The remaining 3 studies assessed telematic services for monitoring patients suffering from uncontrolled hypertension [72,73], as well as for interventions in stroke rehabilitation [74].
All clinical trials were conducted in samples from 170 up to 400 individuals. The mean time between the kick-off of a clinical trial (i.e., the registration year) and the respective publication year was 4.3 years.
● J00–J99: Diseases of the respiratory system (3 studies/2 trials): The trials of this health domain studied tele-monitoring [75] and mobile-based services [75,76] for patients suffering from asthma.
Clinical trials were conducted over a sample size from 12 to 312 individuals. We recorded an average time period of nearly 4 years between the registration of a clinical trial and its publication year.
● Z00–Z99: Factors influencing health status and contact with health services (8 studies/7 trials): In [77], the authors studied the ICT-enabled prevention through a computerized virtual advisor. One trial in two other studies [78,79] assessed CBA systems for treatment via Internet and mobile technologies for diet, nutrition disorders and exercise. Similarly, the same assessments via Internet and mobile technologies were performed for activities of daily living [80], as well as for the health behavior domain [81]. We also reviewed studies that assessed the role of online-based education systems. Apart from increasing symptom awareness [82], the authors of the work described in [83] compared a tablet-PC-based learning approach to conventional education for improving immunosuppression. Finally, the study described in [84] examined individuals’ engagement in an ICT-based physical activity and nutrition intervention especially for men.
All clinical trials were conducted over samples varying from 10 to 504 participants. The mean time between the initiation of the clinical trial (i.e., the registration year) and its related publication was approximately 2.9 years.
● Other subjects (older adults, reproductive health and childbirth, screening for partner violence) (4 studies/3 trials): Four studies in this review do not explicitly fall into the previous ICD-10 categories, but still employ HITs. Among them, the work described in [85] refers to older adults, [86,87] refer to antenatal care and interventions for the reduction of perinatal mortality respectively, while [88] refers to screening for partner violence.
The samples of the clinical trials span from 24 to 2550 individuals. The average time period between the registration of a clinical trial and its publication year was close to 2 years.

3.2. Synthesis of the Characteristics and Findings

As already mentioned, we considered 55 articles published in 42 different journals that employ 51 RCTs in total.
The reliability of the findings is strengthened, as most of the studies included delineate a large proportion of low-risk bias assessment, mainly in the types of selection, attrition and reporting bias (Table 1).
Although RCTs provide strong evidence in the scopes of the examined studies, we noticed that the average time between the registration of a clinical trial until the related publication is nearly three years. This means that apart the time needed for the final publication of each article (submission, review, revision phase, etc.), there is still a significant time period required for applying ICTs in clinical medicine (i.e., the management of a clinical protocol and trial) (Table 2).
Now, as far as the Health Information Technology category (i.e., Section 2. of SF/HIT) is concerned (Figure 2), our analytical findings (Table 2), with respect to RQ3, are:
Development sub-category (i.e., sub-category 2.1. of SF/HIT): 14 trials support all types of Computer Communication Networks including Internet (MeSH term: L01.224.230.110 (Figure 3)), of which 9 offer positive results (64.3%). Also, 4 of 6 trials that support Telemedicine (MeSH term: L01.178.847.652) offer positive results (66.7%). 26 trials support the use of Smartphones and Text Messaging technologies of information science (MeSH terms: L01.178.847.698.300.250 and L01.178.847.698.300.500), describing 50% positive outputs. 1 of 3 trials of User-Computer Interface or Virtual Systems (MeSH term: L01.224.900.910) offer positive results (33.3%). Finally, 14 trials support all types of Medical Informatics Applications (MeSH term: L01.313.500.750), of which 9 offer positive results (64.3%) (Table 2).
According to their experimental type, 47.1% of the RCTs fall within the treatment type, 7.8% refer to screening type while the rest of them belong to prevention (15.7%), supportive care (15.7 %), health services research (13.7%) and none in the diagnostic type (0%) (Table 2).
Functionality sub-category (i.e., sub-category 2.2. of SF/HIT): The majority of trials (27) were related to CBA. 14 of them (51.9%) were assessed to have positive outputs. 6 trials support DSS with 100% positive results. The rest of them, i.e., CPOE, EHR and Other types of systems, were assessed with 50%, 50% and 68.4% positive values, respectively (Table 2). These results are also fairly similar to those reported in [25], where strong evidence supports the use of clinical DSS and CPOE.
Evaluation sub-category (i.e., sub-category 2.3. of SF/HIT): In this sub-category we examine the following three parameters:
(a) Standard evaluation report: Despite the fact that CONSORT-EHEALTH (i.e., sub-category 2.3.1. of SF/HIT) improves and standardizes the evaluation reports of Web-based and mobile health interventions [10], yet we found only 3 studies [59,60,61] that comply with it.
(b) Dimension of impacts by type (i.e., sub-category 2.3.2. of SF/HIT): Similar to the outcomes of [6], our research confirmed that RCTs remain the gold standard for assessing the effectiveness, preventive care, safety/privacy, appropriateness, satisfaction, service delivery/performance, usefulness and adherence/attendance. In our study, we identified the above-mentioned outcomes as well as some more (i.e., process of service delivery/performance, acceptability, cost effectiveness, and satisfaction). Furthermore, in accordance with [19], we classified them into five major categories in accordance with safety, efficacy/effectiveness, psychological/social/ethical and organizational/professional aspects of assessment.
Moreover, with respect to RQ4, we observed positive results in: (i) preventive care (6 out of 7 trials—85.7%); (ii) acceptability (6 out of 8 trials—75%); (iii) safety/privacy/security (4 out of 6 trials—66.7%); (iv) appropriateness (2 out of 3—66.7%); (v) effectiveness (26 out of 45—57.8%); (vi) satisfaction (3 out of 5—60%); (vii) service delivery/performance (3 out of 5—60%); (viii) usefulness (4 out of 7—57.1%); and (ix) adherence/attendance (5 out of 10—50%). Lower levels of positive results appeared in cost effectiveness (only 1 out of 6 trials—16.7%) and efficiency (1 out of 3 trials—33.3%) (Table 3).
(c) Dimension of impacts by rating (i.e., sub-category 2.3.3. of SF/HIT): Although in our study we classified the effects into two main groups (positive/mixed positive (the use of HITs has Positive or Mixed (at least one positive and one neutral or negative) influence on the results (impacts)) and neutral/negative (the use of HITs has Neutral or Negative influence on the results (impacts)), we noticed that our findings are in line with [25], where the authors reported that 56% of their examined studies presented positive results, and 21% presented mixed-positive results. That is, in our work, similarly to [25], we identified significant improvements in the quality of healthcare provision through the use of HITs (31 out of 51 trials—60.8%) (Table 3). The majority of them (24 trials) belong to the experimental treatment type, while all of them were assessed as having positive summary outcomes (Table 2).

4. Discussion

This review outlines the environment in which HIT and computer-based tools are applied to support evidence-based medicine.
To assist other researchers in taking the correct actions and producing tangible and reusable results, we ensured that all relevant studies employed the same types of coding and classifications (e.g., MeSH, functional capabilities of HITs, etc.) and similar metrics (e.g., in respect to adherence, efficiency, satisfaction, etc.).
More analytically, a detailed review methodology is provided in Section 2. As far as clinical trials (i.e., RCTs) are concerned, the framework is already quite strict, thus several elements described in Table 2 are already included in the relevant studies (e.g., RCT type and experimental type). However, we believe that it would be useful in future studies to include: (i) the functional capabilities of HITs; (ii) the information science domains; and (iii) categorization of the impact (e.g., adherence, efficiency) under the ICD-10 classification scheme (Table 3).
For the purposes of this study, most of these data were gathered by the authors and many of them were approximate. Also, either heterogeneous data were provided, or they were considered to be ambiguous. For these reasons, it was not possible to undertake a meta-analysis when the results and the conclusions drawn are not completely accurate and error-free.
Therefore, for the improvement of health service delivery through the successful integration of HITs, researchers should provide: (a) adequate and analytical assessment outputs; (b) a common framework for the evaluation of HITs to enhance evaluation and comparability issues; and (c) a standardized reporting mechanism on the extensive application of HITs in evidence-based medicine.
Towards this direction, the SF/HIT framework and the relative guide were presented and validated through a Delphi consultation and adopted as a valuable methodology. This framework, if it is taken into account both in the design of RCTs and systematic reviews, will help researchers to better evaluate HITs and expand their reviews and/or meta-analyses.
To ensure the highest possible quality of our study, we used the following methodologies.

4.1. Study Quality of the Literature Review

We have applied the literature review in accordance with the Delphi method by means of the Practical Guidance described in [89] for the application and reporting of Delphi procedures that are performed in order to select healthcare quality indicators and the construction of the final SF/HIT.

4.2. Study Quality of the Systematic Review

We conduct a systematic review, since this kind of review is originally used in the medical sciences to examine the effectiveness of health-care interventions and to support the practice of evidence-based medicine. Systematic reviews involve identifying, synthesizing and assessing all available evidence, quantitative and/or qualitative, in order to generate a robust, empirically derived answer to a focused research question. They are highly valuable, improve transparency and emphasize the importance of empirical evidence over preconceived knowledge [90].
In line with the above-mentioned, we follow a sufficiently clear, systematic and thorough search strategy over multiple clinical trial registries and academic digital libraries. We also adopt the PRISMA review methodology to ensure the transparent and complete reporting of our systematic review
Moreover, the systematic review quality was assessed according to basic criteria of the Cochrane Risk of Bias Assessment Tool [5]. The articles included in the systematic review in accordance with our respective decisions were classified into seven Cochrane risk of bias items, with each of them being identified in one of the following three bias risk categories: high, low or uncertain (Table 1). A summary of the CONSORT EHEALTH Checklist [10] was applied in order to assess the quality of health information systems.

4.3. Limitations on the Composition of this Research Work

In our work, we faced limitations and certain types of risks of bias with respect to the heterogeneity of measures and the diverse interpretation of results in many reviewed studies. This mainly happened due to the broad aspect of addressed issues across the different health domains and technology fields under consideration.
Thus, in order to overcome these limitations, we collected supplementary information on the design, implementation and the results of the examined clinical trial (e.g., extra articles upon the study protocol used, results stored in the related registries, etc.).
Moreover, in our research strategy, we applied a two-fold eligibility criterion where the results of the trials are available in the registries and are published also in at least one article that belongs to well-known and established scholar databases and vice versa.
Furthermore, in order to assess risk of bias in the included studies we used the Cochrane Risk of Bias Assessment Tool (see also: Section 4.2 and Table 1).
Besides minimizing the selection bias of our systematic review, we used the PRISMA method (also see: Section 4.2, Flow diagram in Figure 1 and PRISMA 2009 Checklist in the Supplementary Materials).
Finally, as Buntin et al. [26] identified, including substantial and tangible criteria in the studies makes the measurements more accurate. Thus, following the SF/HIT framework, the conducting of reviews and meta-analyses will provide sufficient, comparable and reliable results, thus minimizing any type of risk of bias by defining a common set of criteria (e.g., participants, type of clinical trial, medical domain, technological field, etc.) that support measurements by type and by rate.

5. Conclusions

According to our findings, it appears that research surrounding Internet, telemedicine, smartphones and text messaging technologies, user-computer interfaces and virtual systems, as well as medical informatics applications, dominates the literature. Most of them are related to the development of CBA, CPOE and EHR systems. In addition, RCTs study mental, behavioral and neurodevelopmental disorders, nutritional, metabolic and circulatory diseases, as well as factors that are related to health status communication with health services.
Nevertheless, there are some state-of-the-art HIT-based approaches, namely wearable biosensors, artificial intelligence and machine learning systems for health monitoring and delivery that are underrepresented in this work, mainly due to their recent appearance in the field and the necessary time before the publication of the results of an RCT.
Finally, to improve health service delivery, RCTs apply and exhibit a clear formalization by providing measurable outputs that can be compared and evaluated in respect to several HIT-based categories and domains. Towards this direction, we propose the SF/HIT framework in order to classify the findings of our study in two categories and subcategories. The use SF/HIT provides unique insights with respect to HITs and health care delivery assessment in evidence-based medicine by (i) revealing the required healthcare quality indicators (i.e., the measurements) for the implementation of an RCT study over HITs, and (ii) helping the researchers to carry out the appropriate studies and evaluations and/or meta-analyses and extend their systematic reviews.

Supplementary Materials

The following are available online at https://www.mdpi.com/2227-9032/6/3/109/s1, sup_basic.pdf: supplementary file, SF-HIT.pdf: the proposed SF/HIT Framework, PRISMA.pdf: PRISMA 2009 Checklist.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

AbbreviationInterpretation
ANZCTRAustralian and New Zealand Clinical Trials Registry
AHRQ'sAgency for Healthcare Research and Quality’s
CBAComputer-based alerts and reminders systems
ChiCTRChinese Clinical trial registry
ClinicalTrials.govUnited States Trials Registry
CMSCenters for Medicare & Medicaid Services
Cochrane libraryCochrane Central Register of Controlled Trials
CONSORTConsolidated Standards of Reporting Trials
CPOEComputerized Physician Order Entry
CTRIClinical Trials Registry – India
DRKSDeutsches Register Klinischer Studien (German Clinical Trials Register)
DSSDecision Support Systems
EBHIEvidence-Based Health Informatics
EHRElectronic Health Record
EU Clinical Trials RegisterEuropean Clinical Trials Database
EudraCTThe European Clinical Trials Database
Google ScholarGoogle Scholar
HITHealth Information Technology
HITECHHealth Information Technology for Economic and Clinical Health
HL7Health Level 7
HTAHealth Technology Assessment
ICDInternational Statistical Classification of Diseases and Related Health Problems
ICMJEInternational Committee of Medical Journal Editors
ICTInformation & Computer Technology
ICTRPInternational Clinical Trials Registry Platform
IEEE XploreIEEE Xplore
IRCTIranian Registry of Clinical Trials
ISRCTNInternational Standardised Randomised Controlled Trial Number
JPRNJapan Primary Registries Network
LinkedCTLinked Clinical Trials
Medline/PubMedMedline/PubMed
MeSHMedical Subject Headings
NTRThe Netherlands National Trial Register
PACTRPan African Clinical Trials Registry
PRISMAPreferred Reporting Items for Systematic Reviews and Meta-Analyses
RCTRandomized Controlled Trials
RQResearch Question
ScopusScopus
SF/HITSynthesis Framework for the Assessment of Health Information Technology
WHO ICTRPWHO International Clinical Trials Registry Platform
WHO library databasesWorld Health Organization library databases
Wiley Online LibraryWiley Online Library

References

  1. Ammenwerth, E.; De Keizer, N. A viewpoint on evidence-based health informatics, based on a pilot survey on evaluation studies in health care informatics. J. Am. Med. Inform. Assoc. 2007, 14, 368–371. [Google Scholar] [CrossRef] [PubMed]
  2. Sargeant, J.M.; Kelton, D.F.; O’Connor, A.M. Study designs and systematic reviews of interventions: Building evidence across study designs. Zoonoses Public Health 2014, 61, 10–17. [Google Scholar] [CrossRef] [PubMed]
  3. Christopoulou, S.C.; Kotsilieris, T.; Anagnostopoulos, I. Evidence-based health and clinical informatics: A systematic review on randomized controlled trials. Health Technol. 2017, 8, 1–14. [Google Scholar] [CrossRef]
  4. Dalkey, N.; Helmer, O. An experimental application of the Delphi method to the use of experts. Manag. Sci. 1963, 9, 458–467. [Google Scholar] [CrossRef]
  5. Higgins, J.P.; Green, S. Cochrane Handbook for Systematic Reviews of Interventions; Version 5.1.0; The Cochrane Collaboration: London, UK, 2011. [Google Scholar]
  6. Petticrew, M.; Roberts, H. Evidence, hierarchies, and typologies: Horses for courses. J. Epidemiol. Community Health 2003, 57, 527–529. [Google Scholar] [CrossRef] [PubMed]
  7. Sackett, D.L.; Rosenberg, W.M.; Gray, J.; Haynes, R.B.; Richardson, W.S. Evidence based medicine: What it is and what it isn’t. BMJ Br. Med. J. 1996, 312, 71–72. [Google Scholar] [CrossRef]
  8. Jonas, W.B. The evidence house: How to build an inclusive base for complementary medicine. West. J. Med. 2001, 175, 79. [Google Scholar] [CrossRef] [PubMed]
  9. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann. Intern. Med. 2009, 151, 264–269. [Google Scholar] [CrossRef] [PubMed]
  10. Eysenbach, G.; Group, C.-E. CONSORT-EHEALTH: Improving and standardizing evaluation reports of Web-based and mobile health interventions. J. Med. Internet Res. 2011, 13, e126. [Google Scholar] [CrossRef] [PubMed]
  11. Wu, R.; Appel, L.; Morra, D.; Lo, V.; Kitto, S.; Quan, S. Short message service or disService: Issues with text messaging in a complex medical environment. Int. J. Med. Inf. 2014, 83, 278–284. [Google Scholar] [CrossRef] [PubMed]
  12. Sittig, D.F.; Gonzalez, D.; Singh, H. Contingency planning for electronic health record-based care continuity: A survey of recommended practices. Int. J. Med. Inform. 2014, 83, 797–804. [Google Scholar] [CrossRef] [PubMed]
  13. Law, L.M.; Wason, J.M. Design of telehealth trials-Introducing adaptive approaches. Int. J. Med. Inform. 2014, 83, 870–880. [Google Scholar] [CrossRef] [PubMed]
  14. Cruz, J.; Brooks, D.; Marques, A. Home telemonitoring in COPD: A systematic review of methodologies and patients’ adherence. Int. J. Med. Inform. 2014, 83, 249–263. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Ammenwerth, E.; Duftschmid, G.; Gall, W.; Hackl, W.O.; Hoerbst, A.; Janzek-Hawlat, S.; Jeske, M.; Jung, M.; Woertz, K.; Dorda, W. A nationwide computerized patient medication history: Evaluation of the Austrian pilot project “e-Medikation”. Int. J. Med. Inform. 2014, 83, 655–669. [Google Scholar] [CrossRef] [PubMed]
  16. Häyrinen, K.; Saranto, K.; Nykänen, P. Definition, structure, content, use and impacts of electronic health records: A review of the research literature. Int. J. Med. Inform. 2008, 77, 291–304. [Google Scholar] [CrossRef] [PubMed]
  17. Shekelle, P.G.; Goldzweig, C.L. Costs and Benefits of Health Information Technology: An Updated Systematic Review; Health Foundation: London, UK, 2009. [Google Scholar]
  18. WHO. Medical Devices Health Technology Assessment. Available online: http://www.who.int/medical_devices/assessment/en/ (accessed on 10 August 2018).
  19. Busse, R.; Orvain, J.; Velasco, M.; Perleth, M.; Drummond, M.; Jørgensen, T.; Jovell, A.; Malone, J.; Alric, R.; Wild, C.; et al. Best practice in undertaking and reporting health technology assessments: Working Group 4 report. Int. J. Technol. Assess. Health Care 2002, 18, 361–422. [Google Scholar] [CrossRef]
  20. Kristensen, F.B.; Lampe, K.; Chase, D.L.; Lee-Robin, S.H.; Wild, C.; Moharra, M.; Garrido, M.V.; Nielsen, C.P.; Røttingen, J.-A.; Neikter, S.A.; et al. Practical tools and methods for health technology assessment in Europe: Structures, methodologies, and tools developed by the European network for Health Technology Assessment, EUnetHTA. Int. J. Technol. Assess. Health Care 2009, 25, 1–8. [Google Scholar] [CrossRef] [PubMed]
  21. Dixon, B.E.; Zafar, A.; McGowan, J.J. Development of a taxonomy for health information technology. Stud. Health Technol. Inform. 2007, 129, 616–620. [Google Scholar] [PubMed]
  22. Jamal, A.; McKenzie, K.; Clark, M.J. The impact of health information technology on the quality of medical and health care: A systematic review. Health Inf. Manag. J. 2009, 38, 26–37. [Google Scholar] [CrossRef]
  23. Chaudhry, B.; Wang, J.; Wu, S.; Maglione, M.; Mojica, W.; Roth, E.; Morton, S.C.; Shekelle, P.G. Systematic review: Impact of health information technology on quality, efficiency, and costs of medical care. Ann. Intern. Med. 2006, 144, 742–752. [Google Scholar] [CrossRef] [PubMed]
  24. Blumenthal, D. Launching hitech. N. Engl. J. Med. 2010, 2010, 382–385. [Google Scholar] [CrossRef] [PubMed]
  25. Jones, S.S.; Rudin, R.S.; Perry, T.; Shekelle, P.G. Health information technology: An updated systematic review with a focus on meaningful use. Ann. Intern. Med. 2014, 160, 48–54. [Google Scholar] [CrossRef] [PubMed]
  26. Buntin, M.B.; Burke, M.F.; Hoaglin, M.C.; Blumenthal, D. The benefits of health information technology: A review of the recent literature shows predominantly positive results. Health Aff. 2011, 30, 464–471. [Google Scholar] [CrossRef] [PubMed]
  27. Tang, P. Key Capabilities of an Electronic Health Record System; Institute of Medicine of the National Academies: Washington, DC, USA, 2003. [Google Scholar]
  28. National Institute of Health. NIH CLINICAL RESEARCH TRIALS AND YOU—Glossary of Common Terms. Available online: www.nih.gov/health/clinicaltrials/glossary.htm (accessed on 29 November 2014).
  29. National Institutes of Health, Department of Health and Human Services. Clinical Trials Registration and Results Information Submission. Final rule. Fed. Regist. 2016, 81, 64981–65157. [Google Scholar]
  30. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (International Classification of Diseases) (ICD) 10th Revision—Version:2010; World Health Organization: Geneva, Switzerland, 2010; Volume 1. [Google Scholar]
  31. Begg, C.; Cho, M.; Eastwood, S.; Horton, R.; Moher, D.; Olkin, I.; Pitkin, R.; Rennie, D.; Schulz, K.F.; Simel, D.; et al. Improving the quality of reporting of randomized controlled trials: The CONSORT statement. JAMA 1996, 276, 637–639. [Google Scholar] [CrossRef] [PubMed]
  32. Lipscomb, C.E. Medical subject headings (MeSH). Bull. Med. Libr. Assoc. 2000, 88, 265–266. [Google Scholar] [PubMed]
  33. De Angelis, C.D.; Drazen, J.M.; Frizelle, F.A.; Haug, C.; Hoey, J.; Horton, R.; Kotzin, S.; Laine, C.; Marusic, A.; Overbeke, A.J.P.; et al. Is this clinical trial fully registered?—A statement from the International Committee of Medical Journal Editors. N. Engl. J. Med. 2005, 352, 2436–2438. [Google Scholar] [CrossRef] [PubMed]
  34. Clancy, M.J. How to conduct an appraisal of a senior house officer. J. Accid. Emerg. Med. 1999, 16, 371–373. [Google Scholar] [CrossRef] [PubMed]
  35. Stein, J.C.; Navab, B.; Frazee, B.; Tebb, K.; Hendey, G.; Maselli, J.; Gonzales, R. A randomized trial of computer kiosk—Expedited management of cystitis in the emergency department. Acad. Emerg. Med. 2011, 18, 1053–1059. [Google Scholar] [CrossRef] [PubMed]
  36. Pop-Eleches, C.; Thirumurthy, H.; Habyarimana, J.P.; Zivin, J.G.; Goldstein, M.P.; De Walque, D.; Mackeen, L.; Haberer, J.; Kimaiyo, S.; Sidle, J.; et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: A randomized controlled trial of text message reminders. AIDS 2011, 25, 825–834. [Google Scholar] [CrossRef] [PubMed]
  37. Bigna, J.J.R.; Noubiap, J.J.N.; Kouanfack, C.; Plottel, C.S.; Koulla-Shiro, S. Effect of mobile phone reminders on follow-up medical care of children exposed to or infected with HIV in Cameroon (MORE CARE): A multicentre, single-blind, factorial, randomised controlled trial. Lancet Infect. Dis. 2014, 14, 600–608. [Google Scholar] [CrossRef]
  38. Mbuagbaw, L.; Thabane, L.; Ongolo-Zogo, P. Opening communication channels with people living with HIV using mobile phone text messaging: Insights from the CAMPS trial. BMC Res. Notes 2013, 6, 131. [Google Scholar] [CrossRef] [PubMed]
  39. Ybarra, M.L.; Korchmaros, J.D.; Prescott, T.L.; Birungi, R. A randomized controlled trial to increase HIV preventive information, motivation, and behavioral skills in Ugandan adolescents. Ann. Behav. Med. 2015, 49, 473–485. [Google Scholar] [CrossRef] [PubMed]
  40. Lana, A.; Faya-Ornia, G.; López, M.L. Impact of a web-based intervention supplemented with text messages to improve cancer prevention behaviors among adolescents: Results from a randomized controlled trial. Prev. Med. 2014, 59, 54–59. [Google Scholar] [CrossRef] [PubMed]
  41. Kearney, N.; McCann, L.; Norrie, J.; Taylor, L.; Gray, P.; McGee-Lennon, M.; Sage, M.; Miller, M.; Maguire, R. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support. Care Cancer 2009, 17, 437–444. [Google Scholar] [CrossRef] [PubMed]
  42. Meropol, N.J.; Egleston, B.L.; Buzaglo, J.S.; Balshem, A.; Benson, A.B.; Cegala, D.J.; Cohen, R.B.; Collins, M.; Diefenbach, M.A.; Miller, S.M.; et al. A Web-based communication aid for patients with cancer. Cancer 2013, 119, 1437–1445. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Miller, D.P., Jr.; Spangler, J.G.; Case, L.D.; Goff, D.C., Jr.; Singh, S.; Pignone, M.P. Effectiveness of a web-based colorectal cancer screening patient decision aid: A randomized controlled trial in a mixed-literacy population. Am. J. Prev. Med. 2011, 40, 608–615. [Google Scholar] [CrossRef] [PubMed]
  44. Van Wyk, J.T.; Van Wijk, M.A.; Sturkenboom, M.C.; Mosseveld, M.; Moorman, P.W.; van der Lei, J. Electronic Alerts Versus On-Demand Decision Support to Improve Dyslipidemia Treatment A Cluster Randomized Controlled Trial. Circulation 2008, 117, 371–378. [Google Scholar] [CrossRef] [PubMed]
  45. Buckingham, B.A.; Raghinaru, D.; Cameron, F.; Bequette, B.W.; Chase, H.P.; Maahs, D.M.; Slover, R.; Wadwa, R.P.; Wilson, D.M.; Ly, T.; et al. Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis. Diabetes Care 2015, 38, 1197–1204. [Google Scholar] [CrossRef] [PubMed]
  46. Arora, S.; Peters, A.L.; Agy, C.; Menchine, M. A mobile health intervention for inner city patients with poorly controlled diabetes: Proof-of-concept of the TExT-MED program. Diabetes Technol. Ther. 2012, 14, 492–496. [Google Scholar] [CrossRef] [PubMed]
  47. Goodarzi, M.; Ebrahimzadeh, I.; Rabi, A.; Saedipoor, B.; Jafarabadi, M.A. Impact of distance education via mobile phone text messaging on knowledge, attitude, practice and self efficacy of patients with type 2 diabetes mellitus in Iran. J. Diabetes Metab. Disord. 2012, 11, 10. [Google Scholar] [CrossRef] [PubMed]
  48. Ramirez, M.; Wu, S.; Jin, H.; Ell, K.; Gross-Schulman, S.; Sklaroff, L.M.; Guterman, J. Automated remote monitoring of depression: Acceptance among low-income patients in diabetes disease management. JMIR Ment. Health 2016, 3, e6. [Google Scholar] [CrossRef] [PubMed]
  49. Bartholomew, M.L.; Soules, K.; Church, K.; Shaha, S.; Burlingame, J.; Graham, G.; Sauvage, L.; Zalud, I. Managing diabetes in pregnancy using cell phone/internet technology. Clin. Diabetes 2015, 33, 169–174. [Google Scholar] [CrossRef] [PubMed]
  50. Kropff, J.; Del Favero, S.; Place, J.; Toffanin, C.; Visentin, R.; Monaro, M.; Messori, M.; Di Palma, F.; Lanzola, G.; Farret, A.; et al. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial. Lancet Diabetes Endocrinol. 2015, 3, 939–947. [Google Scholar] [CrossRef]
  51. Kay-Lambkin, F.; Baker, A.; Lewin, T.; Carr, V. Acceptability of a clinician-assisted computerized psychological intervention for comorbid mental health and substance use problems: Treatment adherence data from a randomized controlled trial. J. Med. Internet Res. 2011, 13, e11. [Google Scholar] [CrossRef] [PubMed]
  52. Garrido, G.; Barrios, M.; Penadés, R.; Enriquez, M.; Garolera, M.; Aragay, N.; Pajares, M.; Vallès, V.; Delgado, L.; Alberni, J.; et al. Computer-assisted cognitive remediation therapy: Cognition, self-esteem and quality of life in schizophrenia. Schizophr. Res. 2013, 150, 563–569. [Google Scholar] [CrossRef] [PubMed]
  53. Espeland, M.A.; Katula, J.A.; Rushing, J.; Kramer, A.F.; Jennings, J.M.; Sink, K.M.; Nadkarni, N.K.; Reid, K.F.; Castro, C.M.; Church, T.; et al. Performance of a computer-based assessment of cognitive function measures in two cohorts of seniors. Int. J. Geriatr. Psychiatry 2013, 28, 1239–1250. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Hedman, E.; Andersson, E.; Lindefors, N.; Andersson, G.; Rück, C.; Ljótsson, B. Cost-effectiveness and long-term effectiveness of Internet-based cognitive behaviour therapy for severe health anxiety. Psychol. Med. 2013, 43, 363–374. [Google Scholar] [CrossRef] [PubMed]
  55. Hedman, E.; Andersson, G.; Andersson, E.; Ljótsson, B.; Rück, C.; Asmundson, G.J.; Lindefors, N. Internet-based cognitive-behavioural therapy for severe health anxiety: Randomised controlled trial. Br. J. Psychiatry 2011, 198, 230–236. [Google Scholar] [CrossRef] [PubMed]
  56. Proudfoot, J.; Clarke, J.; Birch, M.-R.; Whitton, A.E.; Parker, G.; Manicavasagar, V.; Harrison, V.; Christensen, H.; Hadzi-Pavlovic, D. Impact of a mobile phone and web program on symptom and functional outcomes for people with mild-to-moderate depression, anxiety and stress: A randomised controlled trial. BMC Psychiatry 2013, 13, 312. [Google Scholar] [CrossRef] [PubMed]
  57. Reid, S.C.; Kauer, S.D.; Hearps, S.J.; Crooke, A.H.; Khor, A.S.; Sanci, L.A.; Patton, G.C. A mobile phone application for the assessment and management of youth mental health problems in primary care: A randomised controlled trial. BMC Fam. Pract. 2011, 12, 131. [Google Scholar] [CrossRef] [PubMed]
  58. Tulbure, B.T.; Szentagotai, A.; David, O.; Ștefan, S.; Månsson, K.N.; David, D.; Andersson, G. Internet-delivered cognitive-behavioral therapy for social anxiety disorder in Romania: A randomized controlled trial. PLoS ONE 2015, 10, e0123997. [Google Scholar] [CrossRef] [PubMed]
  59. Van Voorhees, B.W.; Hsiung, R.C.; Marko-Holguin, M.; Houston, T.K.; Fogel, J.; Lee, R.; Ford, D.E. Internal versus external motivation in referral of primary care patients with depression to an internet support group: Randomized controlled trial. J. Med. Internet Res. 2013, 15, e42. [Google Scholar] [CrossRef] [PubMed]
  60. Watts, S.; Mackenzie, A.; Thomas, C.; Griskaitis, A.; Mewton, L.; Williams, A.; Andrews, G. CBT for depression: A pilot RCT comparing mobile phone vs. computer. BMC Psychiatry 2013, 13, 49. [Google Scholar] [CrossRef] [PubMed]
  61. Whittaker, R.; Merry, S.; Stasiak, K.; McDowell, H.; Doherty, I.; Shepherd, M.; Dorey, E.; Parag, V.; Ameratunga, S.; Rodgers, A. MEMO—A mobile phone depression prevention intervention for adolescents: Development process and postprogram findings on acceptability from a randomized controlled trial. J. Med. Internet Res. 2012, 14, e13. [Google Scholar] [CrossRef] [PubMed]
  62. Linder, J.A.; Rigotti, N.A.; Schneider, L.I.; Kelley, J.H.; Brawarsky, P.; Haas, J.S. An Electronic Health Record-Based Intervention to Improve Tobacco Treatment in Primary Care: A Cluster-Randomized Controlled Trial. Arch. Intern. Med. 2009, 169, 781–787. [Google Scholar] [CrossRef] [PubMed]
  63. McClure, J.B.; Anderson, M.L.; Bradley, K.; An, L.C.; Catz, S.L. Evaluating an adaptive and interactive mHealth Smoking Cessation and Medication Adherence Program: A randomized pilot feasibility study. JMIR mHealth uHealth 2016, 4, e94. [Google Scholar] [CrossRef] [PubMed]
  64. Rindal, D.B.; Rush, W.A.; Schleyer, T.K.; Kirshner, M.; Boyle, R.G.; Thoele, M.J.; Asche, S.E.; Thyvalikakath, T.; Spallek, H.; Durand, E.C.; et al. Computer-assisted guidance for dental office tobacco-cessation counseling: A randomized controlled trial. Am. J. Prev. Med. 2013, 44, 260–264. [Google Scholar] [CrossRef] [PubMed]
  65. Whittaker, R.; Dorey, E.; Bramley, D.; Bullen, C.; Denny, S.; Elley, C.R.; Maddison, R.; McRobbie, H.; Parag, V.; Rodgers, A.; et al. A theory-based video messaging mobile phone intervention for smoking cessation: Randomized controlled trial. J. Med. Internet Res. 2011, 13, e10. [Google Scholar] [CrossRef] [PubMed]
  66. Crombie, I.; Falconer, D.; Irvine, L.; Williams, B.; Ricketts, I.; Humphris, G.; Norrie, J.; Rice, P.; Slane, P.W. Reducing alcohol-related harm in disadvantaged men: Development and feasibility assessment of a brief intervention delivered by mobile telephone. Public Health Res. 2013, 1, 1–158. [Google Scholar] [CrossRef] [PubMed]
  67. Gajecki, M.; Berman, A.H.; Sinadinovic, K.; Rosendahl, I.; Andersson, C. Mobile phone brief intervention applications for risky alcohol use among university students: A randomized controlled study. Addict. Sci. Clin. Pract. 2014, 9, 11. [Google Scholar] [CrossRef] [PubMed]
  68. Tamblyn, R.; Eguale, T.; Buckeridge, D.L.; Huang, A.; Hanley, J.; Reidel, K.; Shi, S.; Winslade, N. The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: A cluster randomized trial. J. Am. Med. Inform. Assoc. 2012, 19, 635–643. [Google Scholar] [CrossRef] [PubMed]
  69. Antypas, K.; Wangberg, S.C. Combining users’ needs with health behavior models in designing an internet-and mobile-based intervention for physical activity in cardiac rehabilitation. JMIR Res. Protoc. 2014, 3, e4. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Pfaeffli, L.; Maddison, R.; Whittaker, R.; Stewart, R.; Kerr, A.; Jiang, Y.; Kira, G.; Carter, K.; Dalleck, L. A mHealth cardiac rehabilitation exercise intervention: Findings from content development studies. BMC Cardiovasc. Disord. 2012, 12, 36. [Google Scholar] [CrossRef] [PubMed]
  71. Fjeldsoe, B.S.; Miller, Y.D.; O’Brien, J.L.; Marshall, A.L. Iterative development of MobileMums: A physical activity intervention for women with young children. Int. J. Behav. Nutr. Phys. Act. 2012, 9, 151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. McKinstry, B.; Hanley, J.; Wild, S.; Pagliari, C.; Paterson, M.; Lewis, S.; Sheikh, A.; Krishan, A.; Stoddart, A.; Padfield, P. Telemonitoring based service redesign for the management of uncontrolled hypertension: Multicentre randomised controlled trial. BMJ Br. Med. J. 2013, 346, f3030. [Google Scholar] [CrossRef] [PubMed]
  73. Stoddart, A.; Hanley, J.; Wild, S.; Pagliari, C.; Paterson, M.; Lewis, S.; Sheikh, A.; Krishan, A.; Padfield, P.; McKinstry, B. Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): Cost and cost-effectiveness analysis of a randomised controlled trial. BMJ Open 2013, 3, e002681. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Kizony, R.; Weiss, P.; Feldman, Y.; Shani, M.; Elion, O.; Kizony, R.; Weiss, P.L.; Kizony, R.; Harel, S.; Baum-Cohen, I. Evaluation of a Tele-Health System for upper extremity stroke rehabilitation. In Proceedings of the 2013 International Conference on Virtual Rehabilitation (ICVR), Philadelphia, PA, USA, 26–29 August 2013; pp. 80–86. [Google Scholar]
  75. Malhotra, S.; Musgrave, S.D.; Pinnock, H.; Price, D.; Ryan, D.P. The challenge of recruiting in primary care for a trial of telemonitoring in asthma: An observational study. Pragmat. Obs. Res. 2012, 3, 51–55. [Google Scholar] [PubMed]
  76. Meltzer, E.O.; Kelley, N.; Hovell, M.F. Randomized, cross-over evaluation of mobile phone vs paper diary in subjects with mild to moderate persistent asthma. Open Respir. Med. J. 2008, 2, 72–79. [Google Scholar] [CrossRef] [PubMed]
  77. King, A.C.; Bickmore, T.W.; Campero, M.I.; Pruitt, L.A.; Yin, J.L. Employing virtual advisors in preventive care for underserved communities: Results from the COMPASS study. J. Health Commun. 2013, 18, 1449–1464. [Google Scholar] [CrossRef] [PubMed]
  78. Turner-McGrievy, G.; Tate, D. Tweets, apps, and pods: Results of the 6-month Mobile Pounds Off Digitally (Mobile POD) randomized weight-loss intervention among adults. J. Med. Internet Res. 2011, 13, e120. [Google Scholar] [CrossRef] [PubMed]
  79. Turner-McGrievy, G.M.; Tate, D.F. Weight loss social support in 140 characters or less: Use of an online social network in a remotely delivered weight loss intervention. Transl. Behav. Med. 2013, 3, 287–294. [Google Scholar] [CrossRef] [PubMed]
  80. Batch, B.C.; Tyson, C.; Bagwell, J.; Corsino, L.; Intille, S.; Lin, P.-H.; Lazenka, T.; Bennett, G.; Bosworth, H.B.; Voils, C.; et al. Weight loss intervention for young adults using mobile technology: Design and rationale of a randomized controlled trial—Cell Phone Intervention for You (CITY). Contemp. Clin. Trials 2014, 37, 333–341. [Google Scholar] [CrossRef] [PubMed]
  81. Norman, G.J.; Kolodziejczyk, J.K.; Adams, M.A.; Patrick, K.; Marshall, S.J. Fruit and vegetable intake and eating behaviors mediate the effect of a randomized text-message based weight loss program. Prev. Med. 2013, 56, 3–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Albrecht, U.-V.; Folta-Schoofs, K.; Behrends, M.; von Jan, U. Effects of mobile augmented reality learning compared to textbook learning on medical students: Randomized controlled pilot study. J. Med. Internet Res. 2013, 15, e182. [Google Scholar] [CrossRef] [PubMed]
  83. Suhling, H.; Rademacher, J.; Zinowsky, I.; Fuge, J.; Greer, M.; Warnecke, G.; Smits, J.M.; Bertram, A.; Haverich, A.; Welte, T.; et al. Conventional vs. tablet computer-based patient education following lung transplantation—A randomized controlled trial. PLoS ONE 2014, 9, e90828. [Google Scholar] [CrossRef] [PubMed]
  84. Short, C.E.; Vandelanotte, C.; Dixon, M.W.; Rosenkranz, R.; Caperchione, C.; Hooker, C.; Karunanithi, M.; Kolt, G.S.; Maeder, A.; Ding, H.; et al. Examining participant engagement in an information technology-based physical activity and nutrition intervention for men: The manup randomized controlled trial. JMIR Res. Protocols 2014, 3, e2. [Google Scholar] [CrossRef] [PubMed]
  85. Terrell, K.M.; Perkins, A.J.; Dexter, P.R.; Hui, S.L.; Callahan, C.M.; Miller, D.K. Computerized decision support to reduce potentially inappropriate prescribing to older emergency department patients: A randomized, controlled trial. J. Am. Geriatr. Soc. 2009, 57, 1388–1394. [Google Scholar] [CrossRef] [PubMed]
  86. Lund, S.; Nielsen, B.B.; Hemed, M.; Boas, I.M.; Said, A.; Said, K.; Makungu, M.H.; Rasch, V. Mobile phones improve antenatal care attendance in Zanzibar: A cluster randomized controlled trial. BMC Pregnancy Childbirth 2014, 14, 29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Lund, S.; Rasch, V.; Hemed, M.; Boas, I.M.; Said, A.; Said, K.; Makundu, M.H.; Nielsen, B.B. Mobile phone intervention reduces perinatal mortality in Zanzibar: Secondary outcomes of a cluster randomized controlled trial. JMIR mHealth uHealth 2014, 2, e15. [Google Scholar] [CrossRef] [PubMed]
  88. Ahmad, F.; Hogg-Johnson, S.; Stewart, D.E.; Skinner, H.A.; Glazier, R.H.; Levinson, W. Computer-assisted screening for intimate partner violence and control: A randomized trial. Ann. Intern. Med. 2009, 151, 93–102. [Google Scholar] [CrossRef] [PubMed]
  89. Boulkedid, R.; Abdoul, H.; Loustau, M.; Sibony, O.; Alberti, C. Using and reporting the Delphi method for selecting healthcare quality indicators: A systematic review. PLoS ONE 2011, 6, e20476. [Google Scholar] [CrossRef] [PubMed]
  90. Mallett, R.; Hagen-Zanker, J.; Slater, R.; Duvendack, M. The benefits and challenges of using systematic reviews in international development research. J. Dev. Eff. 2012, 4, 445–455. [Google Scholar] [CrossRef] [Green Version]
Healthcare 06 00109 g001 550
Figure 1. Flow chart of our study selection process (PRISMA 2009 flow diagram).
Figure 1. Flow chart of our study selection process (PRISMA 2009 flow diagram).
Healthcare 06 00109 g001
Healthcare 06 00109 g002 550
Figure 2. Synthesis framework for HTA.
Figure 2. Synthesis framework for HTA.
Healthcare 06 00109 g002
Healthcare 06 00109 g003 550
Figure 3. Taxonomy of HITs based on MeSH terminology.
Figure 3. Taxonomy of HITs based on MeSH terminology.
Healthcare 06 00109 g003
Table
Table 1. The articles included in the review and our respective decision over 7 Cochrane risk of bias items.
Table 1. The articles included in the review and our respective decision over 7 Cochrane risk of bias items.
Healthcare 06 00109 i001
*: 1-Random sequence generation (selection bias); 2-Allocation concealment (selection bias); 3-Blinding of participants and personnel (performance bias); 4-Blinding of outcome assessment (detection bias); 5-Incomplete outcome data (attrition bias); 6: Selective reporting (reporting bias); 7. Other bias.
Table
Table 2. Number and percentage of RCT type, experimental type, functional capabilities of HITs and categories of applied information science for the trials according to ICD-10 category.
Table 2. Number and percentage of RCT type, experimental type, functional capabilities of HITs and categories of applied information science for the trials according to ICD-10 category.
Classification of the Studies Based on the ICD-10 Classification SystemDuration (Year(s))RCT TypePopulationExperimental TypeFunctional Capabilities of HITsCategory of Applied Information Science
Open LabelSingle BlindDouble BlindNot BlindedUnclearPreventionScreeningTreatmentSupportive CareHealth services ResearchCBACPOEDSSEHROtherL01.224.230.110L01.178.847.652L01.178.847.698L01.224.900.910L01.313.500.750
A00–B99: Certain infectious and parasitic diseases Infections (5 studies/5 trials)2.4203001916102113000210301
C00–D49: Neoplasms (4 studies/4 trials)5.25010034220111013010030100
E00–E89: Endocrine, nutritional and metabolic diseases (7 studies/7 trials)1.716001090,042114014030111403
F01-F99: Mental, Behavioral and Neurodevelopmental disorders (18 studies /18 trials)2.724660220,8274011218113942807
I00–I99: Diseases of the circulatory system (6 studies/5 trials)2.60012021249011304010132310
J00–J99: Diseases of the respiratory system (3 studies/2 trials)3.5011000324001101000201100
Z00–Z99: Factors influencing health status and contact with health services (8 studies/7 trials)2.86312001040003123000220511
Other subjects (Older adults, Reproductive Health and Childbirth, Screening for Partner Violence) (4 studies/3 trials)2.67201003784011010100200102
Number of trials 18111417-842487272641914626314
Percentage of total 35.3%21.6%27.5%2.0%13.7% 15.7%7.8%47.1%15.7%13.7%52.9%3.9%11.8%7.8%37.3%27.5%11.8%51.0%5.9%27.5%
Percentage of studies with positive outcome summary 66.7%63.6%57.1 %100 %42.9% 75%100%58.3%25%71.4%51.9%50%100%50%68.4%64.3%66.7%50%33.3%64.3%
Summary of trials:51
Table
Table 3. Impacts and outcomes of the trials (number and rates) according to1CD-10 category.
Table 3. Impacts and outcomes of the trials (number and rates) according to1CD-10 category.
Classification of the Studies Based on the ICD-10 Classification SystemImpact by TypePositive Outcome Summary
SafetyEfficacy/EffectivenessOrganizational/ProfessionalPsychological/Social/EthicalEconomic
Safety/Privacy/SecurityEfficiencyEfficacy/EffectivenessPreventive CareAdherence/AttendanceService Delivery/PerformanceAppropriatenessPerceived Ease of Use/UsefulnessAcceptabilitySatisfactionCost Effectiveness
A00–B99: Certain infectious and parasitic diseases Infections (5 studies/5 trials)123121101121
C00–D49: Neoplasms (4 studies/4 trials)003110000103
E00–E89: Endocrine, nutritional and metabolic diseases (7 studies/7 trials)207102022107
F01–F99: Mental, Behavioral and Neurodevelopmental disorders (18 studies/18 trials)00163420141112
I00–I99: Diseases of the circulatory system (6 studies/5 trials)005001011012
J00–J99: Diseases of the respiratory system (3 studies/2 trials)101010010000
Z00–Z99: Factors influencing health status and contact with health services (8 studies/7 trials)116110220114
Other subjects (Older adults, Reproductive Health and Childbirth, Screening for Partner Violence) (4 studies/3 trials)102011000002
Number of trials that examined this impact6345710737856
Number wherein the examined impact contribute to positive outcome summary41266542463131
Rate wherein the examined impact contribute to positive outcome summary66.7%33.3%57.8%85.7%50%57.1%66.7%57.1%75%60%16.7%60.8%

Share and Cite

MDPI and ACS Style

Christopoulou, S.C.; Kotsilieris, T.; Anagnostopoulos, I. Assessment of Health Information Technology Interventions in Evidence-Based Medicine: A Systematic Review by Adopting a Methodological Evaluation Framework. Healthcare 2018, 6, 109. https://doi.org/10.3390/healthcare6030109

AMA Style

Christopoulou SC, Kotsilieris T, Anagnostopoulos I. Assessment of Health Information Technology Interventions in Evidence-Based Medicine: A Systematic Review by Adopting a Methodological Evaluation Framework. Healthcare. 2018; 6(3):109. https://doi.org/10.3390/healthcare6030109

Chicago/Turabian Style

Christopoulou, Stella C., Theodore Kotsilieris, and Ioannis Anagnostopoulos. 2018. "Assessment of Health Information Technology Interventions in Evidence-Based Medicine: A Systematic Review by Adopting a Methodological Evaluation Framework" Healthcare 6, no. 3: 109. https://doi.org/10.3390/healthcare6030109

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop